Innovations in Cost-Disruptive Tools for Diagnosis and Screening

This Grand Challenge seeks cost-disruptive diagnostic and screening tools designed for low- and middle-income countries (LMICs), defined as devices that amortize capital costs to near-zero incremental cost and consumable tests targeting the $1-class price point. The initiative supports transformative, high-risk innovations including novel sensing modalities, software-defined diagnostics, and AI-enabled approaches that fundamentally rethink diagnosis or screening performance and deployment...